Laminin (925-933): Cell Adhesion and Chemotaxis Peptide for ECM Research

Executive Summary:
Laminin (925-933) is a synthetic peptide that corresponds to residues 925–933 of the laminin beta 1 chain, a central component of the extracellular matrix (ECM) glycoprotein network (APExBIO). This peptide specifically binds the laminin receptor and recapitulates a functional cell attachment domain with direct effects on cell adhesion and migration (Laminin (925-933): Advanced Insights). It stimulates attachment of HT-1080 and CHO cells at 100–300 µg/mL and acts as a chemoattractant for B16F10 melanoma cells, eliciting ~30% of the maximal response of full-length laminin (Taylor et al. 2023). The peptide can competitively inhibit chemotactic responses to laminin, enabling targeted modulation of metastasis and cell migration in vitro. Laminin (925-933) is highly soluble, stable under -20°C conditions, and is intended for research applications including cell adhesion, migration, and ECM signaling studies.

Biological Rationale

Laminin (925-933) is a defined peptide fragment derived from the laminin beta 1 chain, which is one of the three chains (alpha, beta, gamma) forming heterotrimeric laminin molecules. Laminins are major basement membrane proteins that provide structural support, regulate cell differentiation, and mediate signaling in tissues (Taylor et al. 2023). The beta 1 chain contains seven conserved domains and is widely expressed in all basement membrane-producing tissues. The 925–933 region contains a cell attachment motif critical for receptor binding and chemotaxis modulation. Disruption of laminin-integrin or laminin-receptor interactions can alter cell migration, metastasis, and tissue architecture (Laminin (925-933): Advanced Insights). The synthetic peptide enables the dissection of these pathways in vitro with high specificity and reproducibility, outperforming complex protein mixtures in experimental control (Precision Cell Adhesion & Migration).

Mechanism of Action of Laminin (925-933)

Laminin (925-933) (sequence: Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg) mimics a functional domain within the beta 1 chain that binds specifically to the 67 kDa laminin receptor. Upon binding, the peptide modulates integrin-mediated signaling, supporting focal adhesion formation and cytoskeletal reorganization. This leads to enhanced cell attachment and directed migration, primarily by activating downstream signaling pathways such as PI3K/AKT and MAPK/ERK (Precision Modulator for Cell Signaling). In chemotaxis assays, the peptide functions both as a direct chemoattractant and as a competitive inhibitor of full-length laminin, allowing selective investigation of receptor-ligand interactions. The defined structure and receptor selectivity reduce background activity and enhance assay reproducibility compared to native ECM extracts (Enhancing Cell Assays).

Evidence & Benchmarks

• Laminin (925-933) stimulates HT-1080 fibrosarcoma and CHO cell attachment at 100–300 µg/mL, yielding robust adhesion comparable to full-length laminin (APExBIO product page).
• The peptide acts as a chemoattractant for B16F10 murine melanoma cells, eliciting ~30% of the maximal chemotactic response relative to full-length laminin (APExBIO).
• Laminin (925-933) competitively inhibits chemotactic responses to full-length laminin in migration assays, supporting its specificity for the laminin receptor (Taylor et al. 2023).
• The peptide is soluble at ≥15.53 mg/mL in water, ≥17.77 mg/mL in ethanol, and ≥48.35 mg/mL in DMSO, supporting a range of assay conditions (APExBIO).
• Storage at -20°C with short-term solution use maintains peptide stability and functional activity (APExBIO).
• Research using defined ECM fragments like Laminin (925-933) enables advanced interrogation of ECM-driven cell signaling and migration, clarifying disease mechanisms in cancer metastasis and neurodegeneration (Taylor et al. 2023).

This article extends the scenario-driven, lab-focused guidance in Enhancing Cell Assays with Laminin (925-933) by integrating mechanistic benchmarks and translational disease context from recent peer-reviewed findings.

Applications, Limits & Misconceptions

Laminin (925-933) is used in cell-based assays to dissect cell adhesion, migration, and chemotaxis, especially in cancer and neurodegenerative disease models. Its defined sequence and selectivity allow for reproducible, quantitative assessment of ECM-receptor interactions and signaling pathways (Precision Tools for ECM Signaling). The peptide aids in high-throughput screening for metastasis inhibitors, mapping receptor specificity, and benchmarking ECM-dependent functional responses. However, it does not recapitulate the full complexity of the native ECM, nor does it replace full-length laminin in tissue engineering or long-term culture systems.

Common Pitfalls or Misconceptions

• Not a substitute for full-length laminin in structural assays: The peptide lacks the multidomain structure of native laminin, limiting its use in 3D culture or tissue scaffolding.
• Limited functional domains: Laminin (925-933) targets a specific receptor-binding motif and does not engage all ECM receptors or integrins.
• Concentration dependence: Functional effects are observed at 100–300 µg/mL; lower concentrations may yield suboptimal or variable results.
• Species and cell-type specificity: Not all cell lines express the required laminin receptor; activity must be verified empirically.
• Not for diagnostic or therapeutic use: The peptide is for research use only and not validated for clinical applications.

Workflow Integration & Parameters

APExBIO’s Laminin (925-933) (SKU: A1023) is supplied as a solid peptide (MW: 967.06 Da). It is soluble in water, ethanol, and DMSO, allowing flexible assay design. For cell adhesion and migration assays, researchers typically prepare peptide solutions at 100–300 µg/mL. Short-term use of diluted solutions is advised to maintain stability. The peptide is compatible with HT-1080, CHO, and B16F10 cell lines in standard buffer conditions. It serves as a positive control or direct modulator in chemotaxis, migration, and receptor blocking experiments. The product is intended for scientific research only (Laminin (925-933) from APExBIO).

Conclusion & Outlook

Laminin (925-933) provides a defined, reproducible tool for dissecting ECM-driven cell adhesion and migration. Its specificity for the laminin receptor and validated benchmarks in chemotaxis and cell attachment make it indispensable for basement membrane protein research, cancer metastasis studies, and extracellular matrix signaling pathway interrogation. This article updates prior summaries by integrating mechanistic findings and disease relevance from recent peer-reviewed studies, supporting the adoption of Laminin (925-933) as an essential peptide in translational research (Taylor et al. 2023). For further mechanistic and translational perspectives, see Laminin (925-933): Precision Modulator for Cell Signaling, which focuses on applications beyond cancer and neurobiology, and Advanced Insights into ECM Signaling, which offers a broader disease model context. Researchers seeking a validated, high-quality cell adhesion and migration peptide can buy Laminin (925-933) from APExBIO to streamline ECM-focused experimental workflows.